Literature DB >> 10096527

Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications.

H Egawa1, M Kasahara, Y Inomata, S Uemoto, K Asonuma, S Fujita, T Kiuchi, M Hayashi, T Yonemura, M Yoshibayashi, Y Adachi, J A Shapiro, K Tanaka.   

Abstract

BACKGROUND: In 320 living related liver transplantation performed between June 1990 and September 1997, there were 21 living related liver transplantation for patients with intrapulmonary shunting, manifested by digital clubbing, cyanosis, and dyspnea. We report the long-term outcome for more 6 months and our strategy to overcome complications in these recipients. PATIENTS: A total of 21 patients (age range 2-33 years, 19 children and 2 adults, 6 males and 15 females) were classified into three grades according to shunt ratio calculated by TcMAA pulmonary scintigraphy; 5 in mild group (shunt ratio: less than 20%), 6 in moderated group (20%-40%), and 10 in severe group (more than 40%). The original underlying liver disease was biliary atresia in all patients.
RESULTS: Spearmen's correlation coefficient rank test revealed that shunt ratio correlated significantly with PaO2 in room air (P=0.0001), PaO2 in 100% oxygen (P=0.0004), hematocrit (P=0.0276), and period of dyspnea before transplantation (P=0.023). COMPLICATIONS: Wound infection occurred in 80, 66, and 80%, and bile leakage in 20, 0, 40% in mild, moderate, and severe group, respectively. Patients who had portal vein thrombosis, and intracranial complication were classified as severe group and the incidence was 20 and 20%, respectively. The patient actuarial one year survival was 80, 66.7, and 48%, in mild, moderate, and severe group, respectively, although there was no significant difference. All patients who survived improved hepatopulmonary syndrome and the length of period required for the resolution was significantly correlated to the preoperative shunt ratio (P=0.023). COMMENTS: Patients with severe shunting are susceptible to wound infection and bile leak. The trend of higher incidence of portal thrombosis and intracranial complications in the severe group was closely related high hematocrit. Secure surgical technique to reduce bile leak and delayed primary wound closure to reduce wound infection were found to be effective. Anticoagulant therapy by infusing heparin through the portal vein followed by coumadin could prevent fatal portal vein thrombosis without counter risk of fatal cerebral hemorrhage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10096527     DOI: 10.1097/00007890-199903150-00012

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  22 in total

1.  Hepatopulmonary syndromes.

Authors:  M J Krowka
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

2.  Surgical intervention for patent ductus venosus.

Authors:  Arata Kamimatsuse; Yoshiyuki Onitake; Naomi Kamei; Go Tajima; Nobuo Sakura; Taijiro Sueda; Eiso Hiyama
Journal:  Pediatr Surg Int       Date:  2010-10       Impact factor: 1.827

Review 3.  Hepatopulmonary syndrome: What we know and what we would like to know.

Authors:  Israel Grilo-Bensusan; Juan Manuel Pascasio-Acevedo
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 4.  Hepatopulmonary Syndrome and Portopulmonary Hypertension: The Pulmonary Vascular Enigmas of Liver Disease.

Authors:  Michael J Krowka
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-02

5.  Hepatopulmonary Syndrome and Portopulmonary Hypertension.

Authors:  Michael J. Krowka
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-06

6.  Multiple hyperplastic nodules in the liver with congenital absence of portal vein: MRI findings.

Authors:  Baris Turkbey; Musturay Karcaaltincaba; Hulya Demir; Zuhal Akcoren; Aysel Yuce; Mithat Haliloglu
Journal:  Pediatr Radiol       Date:  2006-03-01

7.  Hepatopulmonary Syndrome and Portopulmonary Hypertension.

Authors:  Michael J. Krowka
Journal:  Curr Treat Options Gastroenterol       Date:  2001-12

8.  Reversal of severe hepatopulmonary syndrome in chronic hepatic cirrhosis by living donor liver transplantation: report of two cases.

Authors:  Kefei Chen; Bo Li
Journal:  Surg Today       Date:  2011-03-02       Impact factor: 2.549

9.  Duct-to-duct biliary reconstruction in living donor liver transplantation utilizing right lobe graft.

Authors:  Takatoshi Ishiko; Hiroto Egawa; Mureo Kasahara; Taro Nakamura; Fumitaka Oike; Satoshi Kaihara; Tetsuya Kiuchi; Shinji Uemoto; Yukihiro Inomata; Koichi Tanaka
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

10.  Hepatopulmonary syndrome: use of extracorporeal life support for life-threatening hypoxia following liver transplantation.

Authors:  Geoffrey M Fleming; Timothy T Cornell; Theodore H Welling; John C Magee; Gail M Annich
Journal:  Liver Transpl       Date:  2008-07       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.